ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.444
0.06%
Brent Oil
84.545
-0.18%
Bitcoin
65,160.70
0.30%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Glaukos Corporation (GKOS)

  7. Glaukos Corporation (GKOS) Noticias

GKOS Glaukos Corporation

113.39
1.40 (1.25%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Glaukos Corporation GKOS NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.40 1.25% 113.39 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
111.86 110.86 114.80 113.39 111.99
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202406:10EDGAR2Form 8-K - Current report
14/6/202406:00BWGlaukos Announces Agreements to Exchange $230 Million in..
05/6/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:25EDGAR2Form 144 - Report of proposed sale of securities
30/5/202415:45EDGAR2Form SD - Specialized disclosure report
30/5/202410:33EDGAR2Form 144 - Report of proposed sale of securities
28/5/202406:00BWGlaukos Announces Participation in Upcoming Investor..
20/5/202406:00EDGAR2Form 8-K - Current report
16/5/202418:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:37EDGAR2Form 144 - Report of proposed sale of securities
14/5/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202416:00EDGAR2Form 144 - Report of proposed sale of securities
10/5/202415:30EDGAR2Form 144 - Report of proposed sale of securities
08/5/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202415:22EDGAR2Form 144 - Report of proposed sale of securities
06/5/202414:40EDGAR2Form 144 - Report of proposed sale of securities
01/5/202415:05BWGlaukos Announces First Quarter 2024 Financial Results
16/4/202415:05BWGlaukos Announces the Release of its 2023 Sustainability..
10/4/202406:00BWGlaukos to Release First Quarter 2024 Financial Results..
03/4/202406:00BWGlaukos Receives Permanent J-code for iDose® TR (travoprost..
01/4/202406:00BWGlaukos To Present Numerous Scientific Abstracts at the 2024..
08/3/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:06EDGAR2Form 144 - Report of proposed sale of securities
04/3/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202419:07EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
29/2/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:01EDGAR2Form 144 - Report of proposed sale of securities
28/2/202406:00EDGAR2Form 8-K - Current report
27/2/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:25EDGAR2Form 144 - Report of proposed sale of securities
26/2/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202412:56EDGAR2Form 144 - Report of proposed sale of securities
23/2/202411:45EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:10EDGAR2Form 8-K - Current report
21/2/202415:05BWGlaukos Announces Fourth Quarter and Full Year 2023..
14/2/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202417:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NYSE
GKOS
Glaukos
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados